Publications in collaboration with researchers from Centro de Investigación Biomédica en Red de Cáncer (1)

2024

  1. PIK3CA mutational status in tissue and plasma as a prognostic biomarker in HR+/HER2− breast cancer

    Cancer Medicine, Vol. 13, Núm. 17